Virpax Pharmaceuticals (VRPX) SEC Filings & 10K Form

$2.87
-0.30 (-9.46%)
(As of 04/25/2024 ET)

Recent Virpax Pharmaceuticals SEC Filings

DateFilerForm TypeView
04/18/2024
3:17 PM
Virpax Pharmaceuticals (Filer)
Form S-1
Registration statement under Securities Act of 1933  
03/26/2024
7:15 AM
Virpax Pharmaceuticals (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/26/2024
6:30 AM
Virpax Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/18/2024
5:30 AM
Virpax Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/18/2024
5:30 AM
Virpax Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/01/2024
3:05 PM
Virpax Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/31/2024
3:22 PM
Floyd Eric (Reporting)
Virpax Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/31/2024
3:22 PM
Bruce Gerald W (Reporting)
Virpax Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/31/2024
3:23 PM
Sendrow Jerrold (Reporting)
Virpax Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/31/2024
3:23 PM
Dubin Michael F (Reporting)
Virpax Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/31/2024
3:24 PM
Mathias Sheila (Reporting)
Virpax Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/31/2024
3:25 PM
Jambulingam Thani (Reporting)
Virpax Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/31/2024
3:25 PM
Shah Vinay (Reporting)
Virpax Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/31/2024
3:26 PM
Singh Vanila (Reporting)
Virpax Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/02/2024
9:11 AM
SABBY MANAGEMENT, LLC (Filed by)
Virpax Pharmaceuticals (Subject)
Form SC 13G/A
12/29/2023
6:30 AM
Virpax Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/13/2023
7:30 AM
Virpax Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/07/2023
7:58 AM
Virpax Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/07/2023
8:08 AM
Virpax Pharmaceuticals (Filer)
Form DEF 14A
12/07/2023
7:50 AM
Virpax Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/17/2023
6:30 AM
Virpax Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/17/2023
6:15 AM
Virpax Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/16/2023
3:51 PM
Virpax Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/15/2023
2:03 PM
Virpax Pharmaceuticals (Filer)
Form NT 10-Q
10/11/2023
3:10 PM
Virpax Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/03/2023
8:51 AM
Mathias Sheila (Reporting)
Virpax Pharmaceuticals (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
09/05/2023
8:28 AM
Virpax Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/16/2023
4:00 PM
Shah Vinay (Reporting)
Virpax Pharmaceuticals (Issuer)
Form 4/A
08/16/2023
4:00 PM
Virpax Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/14/2023
8:05 AM
Virpax Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/14/2023
8:15 AM
Virpax Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
06/22/2023
7:14 AM
Virpax Pharmaceuticals (Filer)
Form DEFA14A
06/21/2023
3:16 PM
Virpax Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/21/2023
3:17 PM
Shah Vinay (Reporting)
Virpax Pharmaceuticals (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
06/21/2023
3:18 PM
Shah Vinay (Reporting)
Virpax Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/26/2023
8:00 PM
Bruce Gerald W (Reporting)
Virpax Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NASDAQ:VRPX) was last updated on 4/25/2024 by MarketBeat.com Staff

From Our Partners